Correlation Between Cyteir Therapeutics and Forte Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cyteir Therapeutics and Forte Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyteir Therapeutics and Forte Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyteir Therapeutics and Forte Biosciences, you can compare the effects of market volatilities on Cyteir Therapeutics and Forte Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyteir Therapeutics with a short position of Forte Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyteir Therapeutics and Forte Biosciences.

Diversification Opportunities for Cyteir Therapeutics and Forte Biosciences

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Cyteir and Forte is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Cyteir Therapeutics and Forte Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Forte Biosciences and Cyteir Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyteir Therapeutics are associated (or correlated) with Forte Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Forte Biosciences has no effect on the direction of Cyteir Therapeutics i.e., Cyteir Therapeutics and Forte Biosciences go up and down completely randomly.

Pair Corralation between Cyteir Therapeutics and Forte Biosciences

If you would invest  611.00  in Forte Biosciences on September 17, 2024 and sell it today you would earn a total of  1,315  from holding Forte Biosciences or generate 215.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy4.76%
ValuesDaily Returns

Cyteir Therapeutics  vs.  Forte Biosciences

 Performance 
       Timeline  
Cyteir Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cyteir Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Cyteir Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Forte Biosciences 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Forte Biosciences are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Forte Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Cyteir Therapeutics and Forte Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cyteir Therapeutics and Forte Biosciences

The main advantage of trading using opposite Cyteir Therapeutics and Forte Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyteir Therapeutics position performs unexpectedly, Forte Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Forte Biosciences will offset losses from the drop in Forte Biosciences' long position.
The idea behind Cyteir Therapeutics and Forte Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation